Search Results | Chinese Journal of Pharmacoepidemiology

Home Results

A total of 23 result was found. Results that relate to Cancer

德曲妥珠单抗治疗乳腺癌有效性和安全性的Meta分析

ZHANG Xiaoqing LIU Shuai ZHANG Kai LUAN Wei

DOI：10.12173/j.issn.1005-0698.202403034

Trastuzumab deruxtecan Antibody drug conjugates Breast cancer Efficacy Safety Meta-analysis Randomized controlled trial
Details Download Mobile
信迪利单抗致免疫性肠炎引发肠道大出血1例

MENG Baowei WU Caizhi MA Yongming CHANG Ruitong YANG Xiaogang TIAN Huashan WU Zhiqiang YIN Rui ZHU Zijiang

DOI：10.12173/j.issn.1005-0698.202308020

Sintilimab Non-small cell lung cancer Immune enteritis Intestinal bleeding Adverse drug reactions
Details Download Mobile
替雷利珠单抗一线治疗晚期非小细胞肺癌的快速卫生技术评估

LI Wenyan PAN Xiding JIE Qiong LI Yuanyuan TANG Mufei

DOI：10.12173/j.issn.1005-0698.202405047

Tislelizumab Non-small cell lung cancer First-line treatment Rapid health technology assessment
Details Download Mobile
帕米帕利联合替莫唑胺治疗小细胞肺癌致骨髓抑制1例

YANG Yuchen ZHAO Yuting LI Shiqi GONG Jiayu SU Riguga SUN Yanyan CAI Zhihui

DOI：10.12173/j.issn.1005-0698.202404055

Small cell lung cancer Pamiparib Temozolomide Bone marrow suppression Adverse drug reactions
Details Download Mobile
CDK4/6抑制剂一线治疗HR+/HER2-晚期乳腺癌的快速卫生技术评估

LI Anna XIA Zhengzheng CAI Jiali LIAN Zhuoshi MENG Jun

DOI：10.12173/j.issn.1005-0698.202404064

CDK4/6 inhibitors Endocrine therapy HR+/HER2- advanced breast cancer Rapid health technology assessment
Details Download Mobile
卡瑞利珠单抗联合阿帕替尼治疗三阴性乳腺癌患者有效性及安全性的Meta分析及系统评价

NIU Zhaofeng ZHAI Yanghai GENG Rui

DOI：10.12173/j.issn.1005-0698.202407031

Camrelizumab Apatinib Triple-negative breast cancer Meta-analysis Systematic review
Details Download Mobile
1例尼达尼布致肺癌合并间质性肺炎患者急性肝损伤的药学实践

ZHANG Juan SHEN Lihuan LIU Jiyong WANG Chunmin

DOI：10.12173/j.issn.1005-0698.202407015

Nintedanib Lung cancer with interstitial pneumonia Acute liver injury Pharmaceutical practice
Details Download Mobile
帕博利珠单抗致中毒性表皮坏死松解症1例

HUANG Lingling LI Xialin HUANG Guangyao LUO Peng WANG Weimin WANG Junping

DOI：10.12173/j.issn.1005-0698.202408019

Pembrolizumab Lung cancer Toxic epidermal necrolysis Adverse drug reaction
Details Download Mobile